DIXON WENDY L 4/A
4/A · Black Diamond Therapeutics, Inc. · Filed Jun 30, 2022
Insider Transaction Report
Form 4/AAmended
DIXON WENDY L
Director
Transactions
- Award
Common Stock
2022-06-17$2.03/sh+4,946$10,040→ 4,946 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 16, 2022.